CARLA MOLLINER: Open Payments
NPI 1548225675 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 17 payments from 7 companies in 2025. Trend: 2023 $2,895 · 2024 $1,126 · 2025 $1,403
Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $509 |
| Mallinckrodt Hospital Products Inc. | 2 | $275 |
| Phathom Pharmaceuticals, Inc. | 2 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $115 |
| Madrigal Pharmaceuticals | 1 | $111 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Intercept Pharmaceuticals, Inc. | 2 | $57 |
Products named: TERLIVAZ, VOQUEZNA, XIFAXAN, REZDIFFRA, IQIRVO, OCALIVA.
Industry payments across FL — which companies pay providers there.
